Stefano Alfonsi

CEO, Elos Medtech


In September 2022, I became CEO of Elos Medtech, a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The business has been majority owned by TA Associates since 2021.

I was previously CEO at Corin Group, a leader in orthopaedic innovation. In 2018, I successfully directed the SBO of Corin Group from Hunt Capital Group, IP Investimenti e Partecipazioni and Idea Capital Funds to Permira.

Previously I was also CEO of Inion and Lima Corporate and held senior positions at Johnson & Johnson and Covidien.

I draw on my experiences of leading product and global business development to aid PepTalks members on their private equity journeys.

Stefano's Content


Enquire about joining the PepTalks Community